Particle.news
Health ❯ Healthcare ❯ Clinical Trials
FDA FDA Approval FDA Regulations Regulatory Affairs FDA Approvals Semaglutide Anvisa NHS Treatments NHS Innovations EMA
Merck priced the once-daily 20 mg tablet below injectable alternatives to expand access while a large cardiovascular outcomes trial runs through 2029.
